Recently, witnessed by numerous experts in the field of medical laboratory testing, Oumeng China and Zhejiang Dian Diagnostics signed a new strategic cooperation agreement in Suzhou, Jiangsu.

As a globally renowned provider of overall medical laboratory solutions and a large-scale medical diagnostic service operator in China, the signing of this agreement marks the second collaboration between the two sides after their first three-year strategic cooperation from 2013 to 2015. The aim is to comprehensively promote the improvement of grassroots medical diagnostic project development capabilities and medical service levels through upgrading multiple platforms for deep cooperation, based on their leading advantages and product strengths in their respective fields, Actively aligning with the national strategy of "Healthy China" and responding to the policy of "comprehensively promoting and deepening the reform of the medical and health system towards in-depth development" for the benefit of the people.

Recently, witnessed by numerous experts in the field of medical laboratory testing, Oumeng China and Zhejiang Dian Diagnostics signed a new strategic cooperation agreement in Suzhou, Jiangsu.

On November 29, 2015, Mr. Li Chuan, Vice President of OMG China Group and President of OMG South Asia and East Asia Group, signed a long-term strategic cooperation agreement with Ms. Xu Min, Vice President of Dean Diagnostics. In the next three years, both sides will focus on building a special diagnostic project detection platform for autoimmune diseases, infectious diseases and allergic diseases. Oumeng China, with its unique technological advantages, excellent products, and internationally compliant difficult sample verification services, complements Dean's comprehensive medical diagnostic service network and complete testing project technology. Both parties will jointly promote new projects and enhance the recognition of such characteristic diagnostic projects through a series of customized training for grassroots medical workers, effectively improving the diagnostic ability and level of such difficult cases, Thus ultimately benefiting the vast number of grassroots patients.

The in vitro diagnostic industry in China is in a rapid development stage, but compared to the current advanced level of the foreign in vitro diagnostic market, there is a certain gap in the recognition level and diagnosis and treatment level of diagnostic and treatment indicators. The strategic cooperation between Oumeng China and Dian Diagnostics will achieve win-win cooperation and sustainable development by integrating market resources and complementary brand advantages, and thereby improve the ability to carry out medical diagnosis projects and the overall level of medical laboratory management in China, promoting the upgrading of the medical diagnosis service industry.